Who Benefits from Immunotherapy in Lung Cancer? More Patients than Previously Thought, According to New Research

A new analysis shows that, among patients with metastatic non-squamous non-small cell lung cancer, the benefits of immunotherapy hold true regardless of the presence of a KRAS mutation.

Published Dec 20, 2019


Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.